William Houser, MD
Allergy/ Immunology · Salem, OHNPI 1003809518
Payments from drug & device makers
Across 169 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$468
- AstraZeneca$459
- Kaleo, Inc.$297
- CSL Behring$293
- Amgen$231
- Sanofi$227
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,39799%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 28 | $468 |
| AstraZeneca | 26 | $459 |
| Kaleo, Inc. | 19 | $297 |
| CSL Behring | 14 | $293 |
| Amgen | 10 | $231 |
| Sanofi | 8 | $227 |
| Genentech USA, Inc. | 8 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $191 |
| Optinose US, Inc. | 11 | $185 |
| Pfizer | 6 | $151 |
| Novartis | 7 | $132 |
| Grifols USA, LLC | 4 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
| Biocryst US Sales Co., LLC | 3 | $65 |
| Eyevance Pharmaceuticals LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 1 | $35 |
| Boehringer Ingelheim | 2 | $26 |
| Blueprint Medicines Corporation | 1 | $24 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $17 |
How this compares
Too few allergy/ immunology providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 27 | $106,500 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,069 |
| Azelastine Hcl | 337 | $7,128 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $7,063 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $6,218 |
| Arnuity ElliptaFluticasone Furoate | 12 | $5,781 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 38 | $4,754 |
| Pulmicort FlexhalerBudesonide | 18 | $4,652 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,206 |
| Epinephrine | 18 | $3,121 |
| Fluticasone Propionate HfaFluticasone Propionate | 14 | $2,786 |
| Montelukast Sodium | 241 | $1,740 |
| Levocetirizine Dihydrochloride | 168 | $1,667 |
| Fluticasone Propionate | 149 | $1,282 |
| AsmanexMometasone Furoate | 11 | $1,171 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta | $468 | $16,85039 claims |
| AstraZenecaPulmicort Flexhaler, Symbicort | $459 | $8,85837 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $38 | $6,21820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy/ immunology providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other allergy/ immunology in Salem
- Devi JhaveriCleveland$369K
- Mohan DurveParma$34K
- Michael WaickmanAkron$10K
- Saad SanyurahWadsworth$4K
- Jessica OhCleveland$144
- Thomas ColemanColumbus$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.